Provenance du réseau au premier degré de Olivier Meyer
Entité | Type d'entité | Industrie | |
---|---|---|---|
Université de Paris XI Paris Sud
9
| Extinct | Other Consumer Services | 9 |
Graphique Sociétés connectées au second degré
Relation dans plusieurs entreprises
Sociétés connectées à Olivier Meyer via son réseau personnel
Société | Secteur | Personnes liées | Poste principal |
---|---|---|---|
Axovan AG
Axovan AG Miscellaneous Commercial ServicesCommercial Services Axovan AG conducts biopharmaceutical research and develops pharmaceuticals. Active in pharmaceutical research and development, it focuses on the family of drug targets called G protein-coupled receptors (GPCRs), which are involved in a number of pathologies. It has developed a validated GPCR-based chemical library through its proprietary chem-informatics platform AXADDIS. Its lead product, clasozentan, is an intravenous endothelin receptor antagonist optimized for treating cerebral diseases. It is partnering non-core indication projects (pain, metabolic diseases, inflammation) at earlier stages. The company was founded in 2000 and is headquartered in Allschwil, Switzerland. | Miscellaneous Commercial Services | Chief Executive Officer | |
ZEALAND PHARMA A/S | Pharmaceuticals: Major | Chief Executive Officer | |
GO Capital SAS
GO Capital SAS Investment ManagersFinance GO Capital SAS (GO Capital) is an independent French private equity firm founded 2003 and is headquartered in Saint-Jacques-de-la-Lande. Formerly known as Grand Ouest Gestion SAS, the firm's investors include regional and cooperative banks, Natixis and CDC PME.GO Capital is located in Rennes and focuses primarily on the northwest quarter of France, also known as Grand Ouest, which comprises the Brittany, Poitou-Charentes, Pays de la Loire and Basse Normandie regions. The firm manages the Ouest Ventures fund. | Investment Managers | Private Equity Investor | |
INTEGRAGEN | Medical/Nursing Services | Director/Board Member | |
Groupe hospitalier Pitié-Salpêtrière
Groupe hospitalier Pitié-Salpêtrière Hospital/Nursing ManagementHealth Services Groupe hospitalier Pitié-Salpêtrière is a part of the AP-HP, which is the CHU of Ile-de-France and is based in Paris, France. The AP-HP has 38 hospitals that receive 8.3 million patients every year. The French company provides medical, social, and legal support to victims of violence through its Maison des Femmes program. The private company also has several research chairs in different fields and all of its clinical services are subject to regulatory certification by the Haute Autorité de Santé (HAS). The company uses indicators to regularly evaluate the quality and safety of the care it provides. The company also has a team of social workers who can help patients with their needs outside of the hospital. The company has protocols for cooperation between healthcare professionals to extend the scope of activities of paramedics while ensuring the quality and safety of care. | Hospital/Nursing Management | Corporate Officer/Principal | |
Minka Therapeutics SA
Minka Therapeutics SA Pharmaceuticals: MajorHealth Technology Minka Therapeutics SA develops therapeutic products and diagnostic complementary to current antiretroviral therapy in the treatment of AIDS. The firm provides therapeutic and diagnostic solutions for diseases linked to the immune system through its research on immune dysregulations. The company was founded by Patrice Debre, Vincent Vieillard, Michel Klein, Joël Crouzet, and Robert L. Murphy in 2008 and is headquartered in Evry, France. | Pharmaceuticals: Major | Founder | |
Institut National des Télécommunications | College/University | Graduate Degree | |
NetXP SAS
NetXP SAS Information Technology ServicesTechnology Services NetXP SAS offers information systems services. It specializes in the engineering of technical infrastructures, allowing these for greater adaptability to change, security and performance. The company was founded on June 15, 2001 and is headquartered in Boulogne-Billancourt, France. | Information Technology Services | Chairman | |
Hifield Group
Hifield Group Miscellaneous Commercial ServicesCommercial Services Hifield Group is a holding French company for Almond, Rampar, and Board of Cyber companies. The company is based in Sevres, FR. and has subsidiaries in the United States and France. The CEO of the company is Jean-François Aliotti. | Miscellaneous Commercial Services | Chief Executive Officer | |
Almond SAS
Almond SAS Information Technology ServicesTechnology Services Part of Hifield Group, Almond SAS is a French company that provides cyber security and digital technology services. The company is based in Sevres, France. Jean-François Aliotti has been the CEO of the company since 2019. | Information Technology Services | Chief Executive Officer | |
Applied Materials UK Ltd.
Applied Materials UK Ltd. Engineering & ConstructionIndustrial Services Part of Applied Materials, Inc., Applied Materials UK Ltd. is a leader in materials engineering solutions for the semiconductor, flat panel display, and solar photovoltaic industries. The company was founded in 1980 and is based in Reading, UK. Applied Ventures, LLC, the venture capital arm of Applied Materials, Inc., invests in innovative startups. Applied Materials offers a range of supply chain services to keep tools and fabs operating at peak performance, including transactional spares, expert rebuilds, and forecasted parts management. The British company's fully optimized parts network supports the added complexity of today's and tomorrow's semiconductor and display. | Engineering & Construction | Corporate Officer/Principal | |
ALNYLAM PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
ESSEC Business School | College/University | Masters Business Admin | |
SHIRE | Pharmaceuticals: Major | Corporate Officer/Principal | |
Kaptitude SAS | Director/Board Member | ||
NOVARTIS AG | Pharmaceuticals: Major | Corporate Officer/Principal | |
SANOFI | Pharmaceuticals: Major | Corporate Officer/Principal | |
Igyxos SA
Igyxos SA Pharmaceuticals: MajorHealth Technology Igyxos SA engages in the development of an innovative medical and pharmaceutical technologies in the field of human fertility. It is involved in all phases of development, from the discovery of promising targets to the identification of potential lead compounds. The company was founded by Marie-Christine Maurel and is headquartered in Nouzilly, France. | Pharmaceuticals: Major | Chief Executive Officer | |
Institute of Intercultural Management & Communication | College/University | Graduate Degree | |
Philipps University of Marburg | College/University | Graduate Degree | |
McGill University | College/University | Graduate Degree | |
Verlingue SAS
Verlingue SAS Insurance Brokers/ServicesFinance Verlingue SAS provides insurance brokerage services. Its solutions include employee benefits, property damage, business interruption, liabilities, motor fleets, building trade, transportation, and payment protection. The company was founded in 1933 and is headquartered in Quimper, France. | Insurance Brokers/Services | General Counsel | |
Life Biosciences, Inc.
Life Biosciences, Inc. Electronic Equipment/InstrumentsElectronic Technology Life Biosciences, Inc. engages in the provision of research on aging and age-related diseases. It focuses on altered communication and inflammation, chromosomal instability, cellular senescence, loss of protoeostasis, metabolism, stem cell exhaustion, epigenetic alterations, and mitochondrial dysfunction. The company was founded by David Sinclair and Tristan Alexander Edwards in 2017 and is headquartered in Boston, MA. | Electronic Equipment/Instruments | Corporate Officer/Principal | |
Harvard Business School | College/University | Undergraduate Degree | |
École des Hautes Études Commerciales de Paris | College/University | Masters Business Admin | |
BRAINSTORM CELL THERAPEUTICS INC. | Biotechnology | Chief Operating Officer | |
Biogen France SAS
Biogen France SAS BiotechnologyHealth Technology Biogen France SAS engages in research and development of biotechnology. The company was founded in 1994 and is headquartered in Paris, France. | Biotechnology | President | |
Astrazeneca Produtos Farmaceuticos Ltda | President | ||
Robert Schuman University | College/University | Undergraduate Degree | |
Endeavour Vision SA
Endeavour Vision SA Investment ManagersFinance Endeavour Vision SA (EV) is an independent venture capital firm headquartered in Geneva. EV traces their origins back to 1989 through the convergence of the Vision Capital European team and the Swiss VC firm, Endeavour. EV was co-founded in 2000 by Sven Lingjaerde and Damien Tappy. The firm specializes in providing funding for entrepreneurs in life sciences, biotech, medtech, cleantech and information technology. EV operates in close cooperation with Genevest, an independent investment vehicle which has reached the divestment stage. Their investors in the funds they advise are industrial corporations, family offices, global institutional investors and business leaders in the technology and investment industry. | Investment Managers | Private Equity Analyst | |
Millendo Therapeutics SAS
Millendo Therapeutics SAS Medical SpecialtiesHealth Technology Millendo Therapeutics SAS provides pharmaceutical research services. It engages in the development of biopharmaceutical drugs, proteins and peptides for the treatment of metabolic diseases and rare diseases. The company was founded by Thierry Abribat, André de Villers, Ezio Ghigo and Aart Jan van der Lely on April 23, 2007 and is headquartered in Ecully, France. | Medical Specialties | Director/Board Member | |
OncoEthix SA
OncoEthix SA Pharmaceuticals: MajorHealth Technology OncoEthix SA operates as a clinical stage biotechnology company which develops cancer drugs. Its products include OTX008, OTX015, and OTX009. The company was founded by Esteban Cvitkovic, Jeanne Kay Noel, Yves Paternot, and Patrice Herait in March 2007 and is headquartered in Luzern, Switzerland. | Pharmaceuticals: Major | Director/Board Member | |
École Nationale Supérieure des Mines de Paris | College/University | Undergraduate Degree | |
Mestex AG
Mestex AG Pharmaceuticals: MajorHealth Technology Part of Grünenthal Pharma GmbH & Co. KG, Mestex AG is a Swiss pharmaceutical manufacturing company. The company is based in Basel, Switzerland. The CEO of the company is Olivier Valdenaire. Mestex was acquired by Grünenthal GmbH on April 12, 2021. | Pharmaceuticals: Major | Chief Executive Officer | |
ADOCIA | Pharmaceuticals: Major | Director/Board Member | |
BPIFrance Investissement SAS
BPIFrance Investissement SAS Investment ManagersFinance BPIFrance Investissement SAS (BPIfrance Investissement) is the private equity arm and subsidiary of State-owned Banque Publique d'Investissement in France. Formerly known as CDC Entreprises SAS, the firm was established in 1994 to carry out public-interest missions such as employment creation and momentum initiation in the private equity field. In 2013 they became BPIfrance Investissement when CDC Entreprises, FSI and FSI Régions merged. Headquartered in Paris, BPIfrance Investissement invests of behalf of the Government of France, as well as for third parties including FEI-Fonds Européen d'Investissement, BEI-Banque Européenne d'Investissement and BPCE SA. The firm invests directly or indirectly in SMEs and intermediate-sized companies at all stages of their development. | Investment Managers | Private Equity Investor | |
École Normale Supérieure | College/University | Undergraduate Degree | |
POXEL | Pharmaceuticals: Major | Director/Board Member | |
ABIONYX PHARMA | Pharmaceuticals: Major | Director/Board Member | |
College des Ingenieurs | College/University | Masters Business Admin | |
Echosens SA
Echosens SA Medical SpecialtiesHealth Technology Echosens SA engages in the manufacture of medical imaging equipment. It focuses on developing FibroScan. The company was founded by Laurent Sandrin and Sylvain Yon on June 20, 2001 and is headquartered in Paris, France. | Medical Specialties | Director/Board Member | |
INNATE PHARMA | Pharmaceuticals: Major | Director/Board Member |
Statistiques
Internationale
France | 34 |
Suisse | 7 |
Etats-Unis | 6 |
Danemark | 2 |
Royaume-Uni | 2 |
Sectorielle
Health Technology | 22 |
Consumer Services | 12 |
Finance | 6 |
Commercial Services | 4 |
Health Services | 4 |
Opérationnelle
Director/Board Member | 25 |
Corporate Officer/Principal | 10 |
Chief Executive Officer | 8 |
Graduate Degree | 6 |
Undergraduate Degree | 6 |
Relations les plus connectées
- Bourse
- Insiders
- Olivier Meyer
- Connexions Sociétés